
peterschreiber.media
Bank of America upgrades Cardinal Health (New York Stock Exchange:Kah) to buy from neutral, indicating accelerating growth.
“Cardinal (New York Stock Exchange:Kah) Organic growth in the basic pharma sector has begun to outperform its peers, and this is likely to become more evident over the next year,”
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182811515/image_1182811515.jpg?io=getty-c-w750
Source link